SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: A.J. Mullen who wrote (9872)12/7/2006 8:05:09 AM
From: Iamarangerboy  Respond to of 10280
 
telegram.com

Thursday, December 7, 2006
Sepracor Inc. says study shows no driving link

31 insomnia patients involved in research on Lunesta drug

By Lisa Eckelbecker TELEGRAM & GAZETTE STAFF
leckelbecker@telegram.com

MARLBORO— Pharmaceutical developer Sepracor Inc. said yesterday that people who took the highest dose of the sleep drug Lunesta showed no significant difference the next day in driving ability compared with people who took no sleep drug at all.